Home > Drugs A-Z > Red Cedar Pollen

Red Cedar Pollen (Allermed Laboratories, Inc.)

Available Formats

Dosage Form Package Information Links
INJECTION 30 mL in 1 VIAL, MULTI-DOSE (49643-373-30) Label Information
INJECTION 50 mL in 1 VIAL, MULTI-DOSE (49643-373-50) Label Information
INJECTION 5 mL in 1 VIAL, MULTI-DOSE (49643-373-05) Label Information
INJECTION 10 mL in 1 VIAL, MULTI-DOSE (49643-373-10) Label Information

Complete Red Cedar Pollen Information

  • BOXED WARNING(What is this?)

    WARNINGS

    This allergenic product is intended for use by physicians who are experienced in the administration of allergenic extracts, and the emergency care of anaphylaxis, or for use under the guidance of an allergy specialist.
    This allergenic extract is not directly interchangeable with other allergenic extracts. The initial dose must be based on skin testing as described in the dosage and administration section of this insert. Patients being switched from other types of extracts, such as alum precipitated extracts, should be started as though they were coming under treatment for the first time. Patients should be instructed to recognize adverse reaction symptoms and cautioned to contact the physician's office if reaction symptoms occur. As with all allergenic extracts, severe systemic reactions may occur. In certain individuals these systemic reactions may occur. In certain individuals these reactions may be life threatening. Patients should be observed for at least 20 minutes following treatment, and emergency measures as well as personnel trained in their use should be immediately available in the event of a life threatening reaction.
    This product should not be injected intravenously (see Dosage and Administration). Refer also to the Warnings, Precautions, Adverse Reactions and Overdosage sections below.


  • DESCRIPTION

    Allergenic extract contains the aqueous extractables from allergenic source material in extracting solution containing 0.25% sodium chloride, 0.125% sodium bicarbonate, and 50% glycerol. 0.4% phenol is added as a preservative. The weight by volume value shown on the label is a measurement of extract concentration, rather than extract potency. Extracts for which U.S. standards exist are labeled in allergy units, in addition to w/v strength.


  • CLINICAL PHARMACOLOGY

    Positive skin tests with allergenic extract are the result of histamine release from mast cells sensitized with allergen specific IgE. The exact mechanisms by which immunotherapy relieves symptoms of allergy are still under investigation. Elevations in allergen-specific IgG antibodies and an increase in the activity of T suppressor lymphocytes appear to be some of the immunologic changes that occur from hyposensitization. 1,2,3


  • INDICATIONS AND USAGE

    Allergenic extract may be used as a diagnostic skin test reagent in persons suspected of being sensitive to the allergenic source material from which the extract is made. Skin tests should be used in conjunction with a thorough allergic history to establish the relevance of a given allergen in the etiology of allergic disease. 4,5,6
    Immunotherapy with allergenic extract is indicated in persons suffering from allergic rhinitis, bronchitis, conjunctivitis, urticaria and asthma. The therapeutic efficacy of allergenic extract has been proven in ragweed, grass, and mountain cedar pollinosis, cat-induced asthma and hypersensitivity to hymenoptera venoms. 7-12
    Immunotherapy may be used along with or exclusive of antihistamines and other medications used to control allergic symptoms.


  • CONTRAINDICATIONS

    Allergenic extract should not be administered to a non-allergic person. However, there are no absolute contraindications to the use of allergenic extract for treatment in appropriate individuals. Relative contraindications include: EXTREME SENSITIVITY TO AN ALLERGEN - Determined from the allergic history, or from previous anaphylaxis following skin testing or subcutaneous injection; AUTOIMMUNE DISEASE - Individuals with autoimmune disease may be at risk, due to the possibility of routine immunizations exacerbating symptoms of the underlying disease; PREGNANCY - In limited controlled studies of women receiving allergenic extract during conception and throughout all trimesters of pregnancy, no evidence was found that extract is harmful to the fetus or mother. However, because of the known pharmacologic action of histamine on uterine muscle, any treatment that might result in the release of significant amounts of this mediator should be avoided if possible 13. See Precaution #4; MYOCARDIAL INFARCTION - Patients who have experienced a recent myocardial infarction may not be able to tolerate immunotherapy. As in all of the above circumstances, the benefit to risk ration must be carefully evaluated; BLEEDING DIATHESIS - Patients with a bleeding tendency should not be tested or treated with allergenic extract, unless the physician responsible believes that such procedures are safe to perform.
    Allergenic extract should be temporarily withheld from patients if any of the following conditions exist: (1) severe symptoms of hay fever and/or asthma; (2) infection or flu accompanied by fever; and (3) exposure to excessive amounts of clinically relevant allergens prior to skin testing or immunotherapy.


  • WARNINGS

    The only approved method for determining hypersensitivity to Allermed Laboratories Allergenic Extracts is by diagnostic skin testing (See DOSAGE AND ADMINISTRATION — DIAGNOSIS).
    Physicians who administer allergenic extract should have emergency medication and equipment available to treat anaphylaxis 14. See Precautions, Adverse Reactions and Overdosage below.
    To reduce the risk of anaphylaxis, the following measures must be observed:

    1. Concentrated extract must be diluted before use for intradermal skin testing and for beginning immunotherapy. It should never be injected intravenously during testing or treatment procedures.
    2. Patients who are highly sensitive, determined from clinical findings and test results, may require that treatment start with a very weak concentration of extract, such as 1:10,000,000 v/v.
    3. The dosage of fresh (new) extract given to a patient receiving maintenance injections must be reduced to one-fourth the amount given from the previous (old) lot (See Immunotherapy, last paragraph).
    4. Patients who are transferred to standardized extract after previous treatment with unstandardized extract must be skin tested with serial dilutions, starting with a 1:100,000 v/v dilution of the standardized extract, to determine a safe, non-reacting starting dose.
    5. Patients who are transferred to this extract after treatment with alum precipitated or other modified extract must re-start injections with the beginning recommended dose of this extract.

  • PRECAUTIONS

    1. Extract should be stored at 2°C to 8°C since higher temperatures may adversely affect the stability of the product. Do not freeze.
    2. After the needle is inserted subcutaneously, the plunger should be withdrawn slightly to check for the presence of blood in the syringe. If blood is observed, a new injection should be prepared and given at another site, observing the same precautions.
    3. Treatment with beta-blocking drugs may make patients refractory to the usual dose of epinephrine, in the event epinephrine is required to control an adverse allergic reaction.
    4. PREGNANCY CATEGORY C. Allergenic extract. Animal reproduction studies have not been conducted with allergenic extract. It is also not known whether allergenic extract can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Allergenic extract should be given to a pregnant woman only if clearly needed.
    5. PATIENT INSTRUCTIONS: Patients should be instructed to remain in the physician's office for at least 20 minutes after skin testing and after each treatment injection, and immediately notify the physician if symptoms of a generalized reaction or shock occur.
    6. CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY: Long term studies have not been conducted with allergenic extracts to determine their potential for carcinogenesis, mutagenesis, and impairment of fertility.
    7. LACTATION: Data are not available on the secretion of allergenic extract in human milk and it is not known what affect this might have on the nursing infant.
    8. PEDIATRIC USE: The dose of allergenic extract recommended for children is the same as that used for adults, except in the injection of large doses of extract for treatment. In this case, the amount of extract given to a child may be modified so that the discomfort of the injection is minimized.

  • ADVERSE REACTIONS

    Local Reactions: The occurrence of a hive 5 to 15 minutes after the subcutaneous injection of extract does not require a reduction in dosage. However, a local reaction with edema larger than 2 cm in diameter or swelling and redness that persist for several hours or longer indicates that too much extract has been given. Treatment should be altered as follows:

    1. Additional injections should not be given until all evidence of the reaction has disappeared.
    2. The next injection administered should be 50% of the last non-reacting dose or less, depending upon the size and severity of the local reaction.
    3. Subsequent injections should be continued at the reduced dosage unless the physician responsible for treatment believes that it is safe to increase the dose, and that possible clinical improvement would result form the administration of a larger dose of extract.

    Systemic Reactions:Systemic (generalized) reactions may range from a mild exacerbation of the patient's allergic symptoms to hives, anaphylactic shock, or even death from anaphylaxis. The reaction usually occurs 5 to 20 minutes after injection. As a rule, the more quickly a reaction develops, the more serious it is likely to become. Symptoms may include sneezing, coughing, itching, shortness of breath, abdominal cramps, vomiting, diarrhea, tachycardia, hypotension and respiratory failure in severe cases. The reaction is usually stopped by the subcutaneous injection of Epinephrine HCL 1:1,000 (See Overdosage below). The oral administration of antihistamines and the placement of a tourniquet proximal to the injection site are helpful adjuncts. In the event that additional measures are required, it may be necessary to treat the patient for BRONCHOSPASM with intravenous aminophylline, intravenous fluids and corticosteroids; for HYPOTENSION with vasopressors, volume repletion, isoproterenol and corticosteroids; for LARYNGEAL OBSTRUCTION with oxygen and tracheostomy and for CARDIAC ARREST with cardiopulmonary resuscitation and other appropriate measures.
    Immunotherapy after anaphylaxis should be continued if the cause of the reaction can be identified and appropriate precautions taken to insure that a subsequent reaction does not occur.


  • OVERDOSAGE

    A strong local reaction to the injection of extract may be treated with oral antihistamines and the local application of a cold compress. The dosage must be reduced and additional extract must not be given until all evidence of the reaction has disappeared.
    A systemic reaction following the injection of extract must be treated immediately. Reported procedures include (Ref. #4, vol. 2, p. 888):

    1. 0.01 mL/kg up to 0.2 mL of aqueous epinephrine HCL 1:1000 subcutaneously at the injection site of antigen.
    2. 0.01 mL/kg up to 0.3 mL of aqueous epinephrine HCL 1:1000 subcutaneously at another site.
    3. Diphenhydramine intravenously or intramuscularly, 1.25 mg/kg up to 50 mg.
    4. Tourniquet above the injection site of antigen.

    Specific reactions:

    1. Brochospasm: intravenous aminophylline 4 mg/kg up to 500 mg given over 10 to 15 minutes, aqueous hydrocortisone 5 mg/kg up to 200 mg, oxygen.
    2. Laryngeal edema: oxygen, intubation, tracheostomy.
    3. Hypotension: vasopressors, fluids, corticosteroids.
    4. Cardiac arrest: resuscitation, sodium bicarbonate, defibrillation, antiarrhythmia medications.

  • DOSAGE AND ADMINISTRATION

    Diagnosis: Concentrated extract may be used for scratch or prick testing providing the patient is not extremely sensitive. In this case, the extract should be diluted 10 fold before a scratch or prick test is performed. Extract for intradermal testing must be used as follows:

    a. Patients with a negative scratch or prick test: Patients who do not react who do not react to a valid scratch or prick test should be tested intradermally with 0.05 mL of a 1:1000 v/v dilution of the concentrate. If the test is negative, a second test should be performed with 0.05 mL of a 1:100 v/v dilution or concentrate.
    b. Patients with positive scratch or prick tests: It is not advisable to perform an intradermal skin test if the patient has a positive scratch or prick test.
    c. Patients tested only by the intradermal method: Patients suspected of being highly allergic should be tested with 0.05 mL of a 1:100,000 v/v dilution of the concentrate. A negative test should be followed by repeat tests using 10 fold stronger concentrations until the maximum dose of 0.05 mL of a 1:100 v/v dilution is reached.

    Interpretation of Results
    Scratch and Prick Test
    A negative test shows only a slight red area at the site of scarification or prick penetration. Positive tests are scored as follows:

    1+ Erythema with 5 mm wheal
    2+ Erythema with a 5-10 mm wheal
    3+ Erythema with a 10-15 mm wheal
    4+ Erythema with a wheal 15 mm (or larger) with pseudopodia

    Intradermal Test
    A negative test shows no change in the appearance and size of the 5 mm wheal created by the I.D. injection of 0.05 mL of extract. Positive tests are scored as follows:

    1+ Erythema 10-20 mm with a 5-10 mm wheal
    2+ Erythema 20-30 mm with a 5-10 mm wheal
    3+ Erythema 30-40 mm with a 10-15 mm wheal
    4+ Erythema greater than 40 mm with a 15 mm wheal (or larger) with pseudopodia

    Immunotherapy

    Allergenic extract should be administered subcutaneously in the outer aspect of the upper arm using a sterile tuberculin syringe and needle. The skin should be cleaned with 70% alcohol and aseptic technique should be observed in removing the extract from the vial. Care must be taken to avoid injecting the extract into a blood vessel because of the risk of anaphylaxis.
    Concentrated extract must be diluted before administration to new patients. A 1:100,000 v/v dilution of concentrate is usually satisfactory to start treatment. However, as a precaution against overdose, a skin test with the intended starting dose should be done to help evaluate the patient's sensitivity to the product. If the skin response is larger than 5 mm edema/15 mm erythema, the extract is too strong and must be diluted before it is given subcutaneously. The doses shown in the Dosage Schedule (Table 1) below are recommended unless the patient's skin test response and allergic history indicates that more dilute extract should be used.
    Little is known about the required accumulated dosage of allergen that is needed to relieve symptoms. However, studies have shown that high dose immunotherapy is efficacious in the treatment of allergic rhinitis and asthma. For this reason, treatment with extract from Vial #5 is recommended, providing the patient can tolerate the extract without experiencing local or systemic reactions. Treatment with Vial #6 may be used for patients who have not had adverse reactions to extract in Vial #5 and who require more concentrated extract to control or relieve symptoms.
    Patients who have received allergenic extract for maintenance therapy SHOULD NOT be given the same dose from a fresh vial of extract. IT IS ADVISABLE TO REDUCE THE DOSAGE OF FRESH EXTRACT TO ONE-FOURTH THE AMOUNT GIVEN FROM A PREVIOUS LOT OF EXTRACT MADE AT THE SAME CONCENTRATION AND BY THE SAME FORMULA.

    Table 1 - Suggested Dosage Schedule
    No.
    Vial #1
    1:100,000 w/v
    frequency twice
    weekly
    mL
    Vial #2
    1:10,000 w/v
    frequency twice
    weekly
    mL
    Vial #3
    1:1,000 w/v
    frequency once
    weekly
    mL
    Vial #4
    1:100 w/v
    frequency once
    weekly
    mL
    Vial #5
    1:10 w/v
    frequency every
    two-four weeks
    mL
    Vial #6
    Concentrate
    frequency every
    two-four weeks
    mL
    1
    0.025
    0.025
    0.025
    0.025
    0.025
    0.025
    2
    0.05
    0.05 0.05 0.05 0.05 0.05
    3
    0.10
    0.10
    0.10
    0.10
    0.10
    0.10
    4
    0.15
    0.15
    0.15
    0.15
    0.15
    0.15
    5
    0.20
    0.20
    0.20
    0.20
    0.20
    0.20
    6
    0.25
    0.25
    0.25
    0.25
    0.25
    0.25
    7
    0.30
    0.30
    0.30
    0.30
    0.30
    0.30

  • SUPPLIED

    Allergenic extract is supplied in dropper vials for scratch or prick testing and in 10, 30, and 50 mL vials for bulk use.

    WARRANTY

    Allermed Laboratories, Inc. certifies that allergenic extract prepared within the Laboratories meets the safety and sterility standards of the F.D.A. Because the Laboratories have no control over the conditions under which extract is sued, or the purposes intended, neither a good nor a bad effect following its administration is warranted.
    The users of this product should be aware of the potential dangers involved in the injection of allergenic extract and accept the risk of any consequences resulting from such injections.
    No representatives of the Laboratories may change this warranty whether written, oral or implied. The buyer or user must assume full responsibility for the product after it leaves the premises of the Laboratories.


  • REFERENCES

    1. Levy, D.A., L.M., Lichtenstein, E.O. Goldstein and K. Ishizaka. Immunologic and cellular changes accompanying the therapy of pollen allergy. J. Clinical Investigations. 50:360, 1971.
    2. Evans, R., H. Pence, H. Kaplan and R. Rocklin. The effect of immunotherapy on humoral and cellular response in ragweed hayfever. J. Clinical Investigations. 57:1378, 1976.
    3. Ishizaka, K. Cellular events in the IgE antibody response. Adv. In Immunology. 23:50, 1976.
    4. Middleton, Elliott, Jr., C.E. Reed and E.F. Ellis (Eds.) Allergy, Principles and Practice Vols. 1&2, C.V. Mosby 1978.
    5. Sheldon, J.M., R.G. Lovell and K.P. Matthews. A Manual of Clinical Allergy. W.B. Saunders, 1967.
    6. Nelson, H.S. Diagnostic procedures in allergy. I. Allergy skin testing. Ann. Allergy. 51:411, 1983.
    7. Norma, P.S., W.L. Winkenwerder and L.M. Lichtenstein. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos. J. Allergy. 42:93, 1968.
    8. Milner, F.H. and E.C. Tees. Specific sensitivity to individual grass pollens in some hay fever patients. Clinical Allergy. 2:83, 1972.
    9. Frankland, A.W. and R. Augustine. Grass pollen antigens effective in treatment. Clinical Science. 23:95, 1962.
    10. Pence, H.L., D.Q. Mitchell, R.L. Greely, B.R. Updegraff and H.A. Selfridge. Immunotherapy for mountain cedar pollinosis: a double-blind controlled study. J. Allergy ad Clinical Immunology. 58:39, 1976.
    11. Taylor, W.W., J.L. Ohman, Jr. and F.C. Lowell. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine. J. Allergy and Clinical Immunology. 61:283. 1978.
    12. Lichtenstein, L.M., M.D. Valentine and A.K. Sobotka. Insect allergies. The state of the art. J. Allergy and Clinical Immunology. 61:268, 1978.
    13. Metzger, W.J., E. Turner and R. Patterson. The safety of immunotherapy during pregnancy. J. Allergy and Clinical Immunology. 61:268. 1978.
    14. Ouellette, J.J. Emergency management of allergic reactions. Modern Medicine 99, 1975.

  • Container Label

    Sample Container Label


  • INGREDIENTS AND APPEARANCE
    ALDER, WHITE POLLEN 
    alnus rhombifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-312
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALNUS RHOMBIFOLIA POLLEN (UNII: 7X8HL8GRTM) (ALNUS RHOMBIFOLIA POLLEN - UNII:7X8HL8GRTM) ALNUS RHOMBIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-312-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-312-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-312-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-312-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ALFALFA POLLEN 
    medicago sativa injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-300
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MEDICAGO SATIVA POLLEN (UNII: G515RAI9FY) (MEDICAGO SATIVA POLLEN - UNII:G515RAI9FY) MEDICAGO SATIVA POLLEN 0.02 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-300-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-300-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-300-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-300-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ALKALI BLITE POLLEN 
    suaeda spp. injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-414
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SUAEDA NIGRA POLLEN (UNII: FZU040QDS7) (SUAEDA NIGRA POLLEN - UNII:FZU040QDS7) SUAEDA NIGRA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-414-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-414-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-414-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-414-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ALTERNARIA 
    alternaria alternata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-101
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALTERNARIA ALTERNATA (UNII: 52B29REC7H) (ALTERNARIA ALTERNATA - UNII:52B29REC7H) ALTERNARIA ALTERNATA 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-101-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-101-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-101-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-101-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    AMERICAN ELM POLLEN 
    ulmus americana injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-417
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ULMUS AMERICANA POLLEN (UNII: 89BAT511BD) (ULMUS AMERICANA POLLEN - UNII:89BAT511BD) ULMUS AMERICANA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-417-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-417-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-417-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-417-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ARIZONA ASH POLLEN 
    fraxinus velutina injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-359
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FRAXINUS VELUTINA POLLEN (UNII: LJT6I6Z8FD) (FRAXINUS VELUTINA POLLEN - UNII:LJT6I6Z8FD) FRAXINUS VELUTINA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-359-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-359-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-359-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-359-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ARROYO WILLOW POLLEN 
    salix lasiolepsis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-408
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SALIX LASIOLEPIS POLLEN (UNII: 808UWJ59FI) (SALIX LASIOLEPIS POLLEN - UNII:808UWJ59FI) SALIX LASIOLEPIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-408-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-408-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-408-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-408-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ASPEN POLLEN 
    populus tremuloides injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-398
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS TREMULOIDES POLLEN (UNII: 928OC2TJDA) (POPULUS TREMULOIDES POLLEN - UNII:928OC2TJDA) POPULUS TREMULOIDES POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-398-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-398-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-398-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-398-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ASPERGILLUS FUMIGATUS 
    aspergillus fumigatus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-130
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ASPERGILLUS FUMIGATUS (UNII: X88DF51T48) (ASPERGILLUS FUMIGATUS - UNII:X88DF51T48) ASPERGILLUS FUMIGATUS 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-130-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-130-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-130-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-130-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    AUSTRALIAN PINE POLLEN 
    casuarina equisetifoli injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-335
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CASUARINA EQUISETIFOLIA POLLEN (UNII: OZJ4OE173N) (CASUARINA EQUISETIFOLIA POLLEN - UNII:OZJ4OE173N) CASUARINA EQUISETIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-335-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-335-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-335-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-335-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BAHIA GRASS POLLEN 
    paspalum notatum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-384
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PASPALUM NOTATUM POLLEN (UNII: V003SHB7VK) (PASPALUM NOTATUM POLLEN - UNII:V003SHB7VK) PASPALUM NOTATUM POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-384-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-384-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-384-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-384-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BASSIA POLLEN 
    bassia hyssopifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-323
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BASSIA HYSSOPIFOLIA POLLEN (UNII: 35487N1IC9) (BASSIA HYSSOPIFOLIA POLLEN - UNII:35487N1IC9) BASSIA HYSSOPIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-323-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-323-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-323-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-323-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BEECH POLLEN 
    fagus grandifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-349
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FAGUS GRANDIFOLIA POLLEN (UNII: 34X886W1H4) (FAGUS GRANDIFOLIA POLLEN - UNII:34X886W1H4) FAGUS GRANDIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-349-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-349-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-349-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-349-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BLACK COTTONWOOD POLLEN 
    populus trichocarpa injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-399
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS TRICHOCARPA POLLEN (UNII: H8QYU50Z2D) (POPULUS TRICHOCARPA POLLEN - UNII:H8QYU50Z2D) POPULUS TRICHOCARPA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-399-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-399-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-399-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-399-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BLACK OAK POLLEN 
    quercus velutina injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-451
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS VELUTINA POLLEN (UNII: 294L626TT0) (QUERCUS VELUTINA POLLEN - UNII:294L626TT0) QUERCUS VELUTINA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-451-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-451-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-451-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-451-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BLACK WALNUT POLLEN 
    juglans nigra injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-366
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUGLANS NIGRA POLLEN (UNII: 1BV28146ZR) (JUGLANS NIGRA POLLEN - UNII:1BV28146ZR) JUGLANS NIGRA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-366-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-366-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-366-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-366-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BLACK WILLOW POLLEN 
    salix nigra injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-409
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SALIX NIGRA POLLEN (UNII: 6M2JIH93ZN) (SALIX NIGRA POLLEN - UNII:6M2JIH93ZN) SALIX NIGRA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-409-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-409-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-409-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-409-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BOTRYTIS 
    botrytis cinerea injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-104
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BOTRYTIS CINEREA (UNII: TBW53313S7) (BOTRYTIS CINEREA - UNII:TBW53313S7) BOTRYTIS CINEREA 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-104-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-104-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-104-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-104-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BOTTLEBRUSH POLLEN 
    callistemon citrinus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-330
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CALLISTEMON CITRINUS POLLEN (UNII: 62OII98F1T) (CALLISTEMON CITRINUS POLLEN - UNII:62OII98F1T) CALLISTEMON CITRINUS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-330-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-330-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-330-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-330-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BOX ELDER MAPLE POLLEN 
    acer negundo injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-303
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACER NEGUNDO POLLEN (UNII: P6K070AR8V) (ACER NEGUNDO POLLEN - UNII:P6K070AR8V) ACER NEGUNDO POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-303-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-303-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-303-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-303-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BURNING BUSH POLLEN 
    kochia scoparia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-374
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BASSIA SCOPARIA POLLEN (UNII: 07A108ZKW5) (BASSIA SCOPARIA POLLEN - UNII:07A108ZKW5) BASSIA SCOPARIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-374-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-374-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-374-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-374-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BURROBRUSH POLLEN 
    hymenoclea salsola injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-362
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMBROSIA SALSOLA POLLEN (UNII: 662J7FTA7T) (AMBROSIA SALSOLA POLLEN - UNII:662J7FTA7T) AMBROSIA SALSOLA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-362-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-362-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-362-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-362-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    BURWEED MARSHELDER POLLEN 
    iva xanthifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-365
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CYCLACHAENA XANTHIFOLIA POLLEN (UNII: V80TPZ0T6J) (CYCLACHAENA XANTHIFOLIA POLLEN - UNII:V80TPZ0T6J) CYCLACHAENA XANTHIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-365-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-365-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-365-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-365-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CALIF. BLACK WALNUT POLLEN 
    juglans californica injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-446
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUGLANS CALIFORNICA POLLEN (UNII: 2147EPR64I) (JUGLANS CALIFORNICA POLLEN - UNII:2147EPR64I) JUGLANS CALIFORNICA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-446-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-446-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-446-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-446-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CALIFORNIA JUNIPER POLLEN 
    juniperus californica injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-368
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS CALIFORNICA POLLEN (UNII: 0H1V4V5V9L) (JUNIPERUS CALIFORNICA POLLEN - UNII:0H1V4V5V9L) JUNIPERUS CALIFORNICA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-368-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-368-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-368-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-368-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CALIFORNIA SCRUB OAK POLLEN 
    quercus dumosa injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-403
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS DUMOSA POLLEN (UNII: P5W45RU6E4) (QUERCUS DUMOSA POLLEN - UNII:P5W45RU6E4) QUERCUS DUMOSA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-403-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-403-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-403-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-403-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CANARY GRASS POLLEN 
    phalaris arundinaceae injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-385
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PHALARIS ARUNDINACEA POLLEN (UNII: FAY1Y90VJ9) (PHALARIS ARUNDINACEA POLLEN - UNII:FAY1Y90VJ9) PHALARIS ARUNDINACEA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-385-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-385-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-385-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-385-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CANDIDA 
    candida albicans injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-105
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CANDIDA ALBICANS (UNII: 4D7G21HDBC) (CANDIDA ALBICANS - UNII:4D7G21HDBC) CANDIDA ALBICANS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-105-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-105-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-105-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-105-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CANYON RAGWEED POLLEN 
    ambrosia ambrosioides injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-352
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMBROSIA AMBROSIOIDES POLLEN (UNII: 81214Y871U) (AMBROSIA AMBROSIOIDES POLLEN - UNII:81214Y871U) AMBROSIA AMBROSIOIDES POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-352-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-352-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-352-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-352-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CARELESS WEED POLLEN 
    amaranthus palmerii injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-313
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMARANTHUS PALMERI POLLEN (UNII: 1GH3WV23KH) (AMARANTHUS PALMERI POLLEN - UNII:1GH3WV23KH) AMARANTHUS PALMERI POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-313-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-313-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-313-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-313-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CATTLE EPITHELIA 
    cattle epithelia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-003
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BOS TAURUS SKIN (UNII: 7J12CD6O9L) (BOS TAURUS SKIN - UNII:7J12CD6O9L) BOS TAURUS SKIN 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-003-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-003-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-003-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-003-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CEPHALOSPORIUM 
    cephalosporium roseum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-106
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CEPHALOSPORIUM ROSEUM (UNII: 1756J4PM8P) (CEPHALOSPORIUM ROSEUM - UNII:1756J4PM8P) CEPHALOSPORIUM ROSEUM 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-106-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-106-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-106-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-106-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CHAETOMIUM 
    chaetomium globosum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-107
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CHAETOMIUM GLOBOSUM (UNII: 5016WB8B8A) (CHAETOMIUM GLOBOSUM - UNII:5016WB8B8A) CHAETOMIUM GLOBOSUM 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-107-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-107-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-107-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-107-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CHEAT GRASS POLLEN 
    bromus secalinus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-329
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BROMUS SECALINUS POLLEN (UNII: Q4T1SJ3046) (BROMUS SECALINUS POLLEN - UNII:Q4T1SJ3046) BROMUS SECALINUS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-329-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-329-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-329-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-329-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CHERRY BIRCH POLLEN 
    betula lenta injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-442
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETULA LENTA POLLEN (UNII: JQ5HI5004M) (BETULA LENTA POLLEN - UNII:JQ5HI5004M) BETULA LENTA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-442-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-442-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-442-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-442-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CHINESE ELM POLLEN 
    ulmus pumila injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-419
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ULMUS PUMILA POLLEN (UNII: 030R993R8E) (ULMUS PUMILA POLLEN - UNII:030R993R8E) ULMUS PUMILA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-419-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-419-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-419-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-419-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CLADOSPORIUM 
    cladosporium herbarum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-108
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CLADOSPORIUM HERBARUM (UNII: O64JF11198) (CLADOSPORIUM HERBARUM - UNII:O64JF11198) CLADOSPORIUM HERBARUM 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-108-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-108-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-108-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-108-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COAST LIVE OAK POLLEN 
    quercus agrifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-401
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS AGRIFOLIA POLLEN (UNII: VOT5MA71M7) (QUERCUS AGRIFOLIA POLLEN - UNII:VOT5MA71M7) QUERCUS AGRIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-401-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-401-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-401-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-401-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COAST MAPLE POLLEN 
    acer macrophyllum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-302
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACER MACROPHYLLUM POLLEN (UNII: E4CG5Q55M1) (ACER MACROPHYLLUM POLLEN - UNII:E4CG5Q55M1) ACER MACROPHYLLUM POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-302-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-302-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-302-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-302-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COAST SAGE POLLEN 
    artemisia californica injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-437
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ARTEMISIA CALIFORNICA POLLEN (UNII: 1EDY616508) (ARTEMISIA CALIFORNICA POLLEN - UNII:1EDY616508) ARTEMISIA CALIFORNICA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-437-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-437-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-437-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-437-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COCKLEBUR POLLEN 
    xanthium commune injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-420
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    XANTHIUM STRUMARIUM POLLEN (UNII: 2QOF601J1M) (XANTHIUM STRUMARIUM POLLEN - UNII:2QOF601J1M) XANTHIUM STRUMARIUM POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-420-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-420-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-420-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-420-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COCKROACH, AMERICAN 
    periplaneta americana injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-047
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PERIPLANETA AMERICANA (UNII: 2RQ1L9N089) (PERIPLANETA AMERICANA - UNII:2RQ1L9N089) PERIPLANETA AMERICANA 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-047-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-047-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-047-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-047-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COCKROACH, GERMAN 
    blattella germanica injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-048
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLATELLA GERMANICA (UNII: G9O67I0A8Q) (BLATELLA GERMANICA - UNII:G9O67I0A8Q) BLATELLA GERMANICA 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-048-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-048-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-048-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-048-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COMMON SAGE POLLEN 
    artemisia tridentata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-320
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ARTEMISIA TRIDENTATA POLLEN (UNII: YI19RB8YFD) (ARTEMISIA TRIDENTATA POLLEN - UNII:YI19RB8YFD) ARTEMISIA TRIDENTATA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-320-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-320-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-320-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-320-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CORN POLLEN POLLEN 
    zea mays injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-422
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ZEA MAYS POLLEN (UNII: 74PD8J616H) (ZEA MAYS POLLEN - UNII:74PD8J616H) ZEA MAYS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-422-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-422-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-422-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-422-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COTTON LINTERS 
    cotton linters injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-004
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COTTON FIBER (UNII: 70LDW53ROO) (COTTON FIBER - UNII:70LDW53ROO) COTTON FIBER 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-004-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-004-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-004-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-004-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    COTTONSEED 
    cottonseed injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-005
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COTTON SEED (UNII: DI0ZRJ0MXN) (COTTON SEED - UNII:DI0ZRJ0MXN) COTTON SEED 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-005-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-005-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-005-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-005-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CULTIVATED OAT POLLEN 
    avena sativa injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-322
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AVENA SATIVA POLLEN (UNII: A7IKY24TR7) (AVENA SATIVA POLLEN - UNII:A7IKY24TR7) AVENA SATIVA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-322-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-322-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-322-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-322-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CURVULARIA 
    curvularia lunata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-109
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COCHLIOBOLUS LUNATUS (UNII: 4T82EA86AJ) (COCHLIOBOLUS LUNATUS - UNII:4T82EA86AJ) COCHLIOBOLUS LUNATUS 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-109-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-109-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-109-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-109-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    CYPRESS, ARIZONA POLLEN 
    cupressus arizonica injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-341
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CUPRESSUS ARIZONICA POLLEN (UNII: 232DMH0XVF) (CUPRESSUS ARIZONICA POLLEN - UNII:232DMH0XVF) CUPRESSUS ARIZONICA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-341-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-341-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-341-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-341-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    DANDELION POLLEN 
    taraxacum officinale injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-416
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TARAXACUM OFFICINALE POLLEN (UNII: WQ3S5294XY) (TARAXACUM OFFICINALE POLLEN - UNII:WQ3S5294XY) TARAXACUM OFFICINALE POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-416-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-416-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-416-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-416-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    DATE PALM POLLEN 
    phoenix dactylifera injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-387
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PHOENIX DACTYLIFERA POLLEN (UNII: 2FV55IRB5B) (PHOENIX DACTYLIFERA POLLEN - UNII:2FV55IRB5B) PHOENIX DACTYLIFERA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-387-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-387-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-387-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-387-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    DESERT RAGWEED POLLEN 
    ambrosia dumosa injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-355
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMBROSIA DUMOSA POLLEN (UNII: ZIO18VN6HJ) (AMBROSIA DUMOSA POLLEN - UNII:ZIO18VN6HJ) AMBROSIA DUMOSA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-355-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-355-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-355-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-355-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    DOCK, YELLOW POLLEN 
    rumex crispus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-406
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RUMEX CRISPUS POLLEN (UNII: V825XJG64G) (RUMEX CRISPUS POLLEN - UNII:V825XJG64G) RUMEX CRISPUS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-406-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-406-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-406-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-406-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    DOG HAIR 
    dog hair injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-006
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CANIS LUPUS FAMILIARIS HAIR (UNII: 05S7L91ZTR) (CANIS LUPUS FAMILIARIS HAIR - UNII:05S7L91ZTR) CANIS LUPUS FAMILIARIS HAIR 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-006-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-006-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-006-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-006-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    EASTERN COTTONWOOD POLLEN 
    populus deltoides injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-395
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS DELTOIDES POLLEN (UNII: 476DVV63WP) (POPULUS DELTOIDES POLLEN - UNII:476DVV63WP) POPULUS DELTOIDES POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-395-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-395-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-395-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-395-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    EASTERN SYCAMORE POLLEN 
    platanus occidentalis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-391
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PLATANUS OCCIDENTALIS POLLEN (UNII: E03U1K03LK) (PLATANUS OCCIDENTALIS POLLEN - UNII:E03U1K03LK) PLATANUS OCCIDENTALIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-391-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-391-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-391-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-391-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    EASTERN WHITE PINE POLLEN 
    pinus strobus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-388
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PINUS STROBUS POLLEN (UNII: TX1ER5UV3T) (PINUS STROBUS POLLEN - UNII:TX1ER5UV3T) PINUS STROBUS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-388-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-388-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-388-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-388-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ENGLISH PLANTAIN POLLEN 
    plantago lanceolata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-389
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PLANTAGO LANCEOLATA POLLEN (UNII: DO87T1U2CI) (PLANTAGO LANCEOLATA POLLEN - UNII:DO87T1U2CI) PLANTAGO LANCEOLATA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-389-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-389-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-389-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-389-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ENGLISH WALNUT POLLEN 
    juglans regia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-367
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUGLANS REGIA POLLEN (UNII: ARW43087I1) (JUGLANS REGIA POLLEN - UNII:ARW43087I1) JUGLANS REGIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-367-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-367-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-367-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-367-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    EPICOCCUM 
    epicoccum nigrum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-110
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EPICOCCUM NIGRUM (UNII: 87U156LEN7) (EPICOCCUM NIGRUM - UNII:87U156LEN7) EPICOCCUM NIGRUM 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-110-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-110-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-110-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-110-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    EUCALYPTUS POLLEN 
    eucalyptus globulus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-347
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EUCALYPTUS GLOBULUS POLLEN (UNII: 7XW7TB10X9) (EUCALYPTUS GLOBULUS POLLEN - UNII:7XW7TB10X9) EUCALYPTUS GLOBULUS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-347-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-347-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-347-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-347-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    EUROPEAN OLIVE POLLEN 
    olea europea injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-383
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OLEA EUROPAEA POLLEN (UNII: 43R41XZ627) (OLEA EUROPAEA POLLEN - UNII:43R41XZ627) OLEA EUROPAEA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-383-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-383-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-383-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-383-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    FALSE RAGWEED POLLEN 
    ambrosia acanthicarpa injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-351
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMBROSIA ACANTHICARPA POLLEN (UNII: U2AI3H2J5Y) (AMBROSIA ACANTHICARPA POLLEN - UNII:U2AI3H2J5Y) AMBROSIA ACANTHICARPA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-351-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-351-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-351-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-351-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    FLAXSEED 
    flaxseed injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-010
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FLAX SEED (UNII: 4110YT348C) (FLAX SEED - UNII:4110YT348C) FLAX SEED 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-010-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-010-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-010-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-010-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    FREMONT COTTONWOOD POLLEN 
    populus fremontii injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-396
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS FREMONTII POLLEN (UNII: 426RHB4302) (POPULUS FREMONTII POLLEN - UNII:426RHB4302) POPULUS FREMONTII POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-396-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-396-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-396-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-396-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    FUSARIUM 
    fusarium solani injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-111
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HAEMATONECTRIA HAEMATOCOCCA (UNII: 7TLR512M4A) (HAEMATONECTRIA HAEMATOCOCCA - UNII:7TLR512M4A) HAEMATONECTRIA HAEMATOCOCCA 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-111-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-111-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-111-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-111-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GAMBELS OAK POLLEN 
    quercus gambelii injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-404
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS GAMBELII POLLEN (UNII: 9HC15X34LX) (QUERCUS GAMBELII POLLEN - UNII:9HC15X34LX) QUERCUS GAMBELII POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-404-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-404-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-404-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-404-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GIANT RAGWEED POLLEN 
    ambrosia trifida injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-317
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMBROSIA TRIFIDA POLLEN (UNII: KU1V1898XX) (AMBROSIA TRIFIDA POLLEN - UNII:KU1V1898XX) AMBROSIA TRIFIDA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-317-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-317-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-317-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-317-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GLYCEROL-SALINE CONTROL 
    glycerol-saline diluent injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-818
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN 0.53 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-818-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-818-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-818-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-818-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GOAT EPITHELIA 
    goat epithelia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-011
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CAPRA HIRCUS SKIN (UNII: JLG9853E2P) (CAPRA HIRCUS SKIN - UNII:JLG9853E2P) CAPRA HIRCUS SKIN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-011-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-011-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-011-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-011-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GRAMA GRASS POLLEN 
    bouteloua spp. injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-326
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BOUTELOUA GRACILIS POLLEN (UNII: 2XO08315X1) (BOUTELOUA GRACILIS POLLEN - UNII:2XO08315X1) BOUTELOUA GRACILIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-326-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-326-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-326-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-326-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GRAY (WHITE) BIRCH POLLEN 
    betula populifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-325
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETULA POPULIFOLIA POLLEN (UNII: 23H70FYJ5U) (BETULA POPULIFOLIA POLLEN - UNII:23H70FYJ5U) BETULA POPULIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-325-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-325-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-325-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-325-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GREASEWOOD POLLEN 
    sarcobatus vermiculatus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-411
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SARCOBATUS VERMICULATUS POLLEN (UNII: 6532U64A3X) (SARCOBATUS VERMICULATUS POLLEN - UNII:6532U64A3X) SARCOBATUS VERMICULATUS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-411-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-411-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-411-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-411-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GREEN ASH POLLEN 
    fraxinus pennsylvanica injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-358
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FRAXINUS PENNSYLVANICA POLLEN (UNII: 2WZG2G15WX) (FRAXINUS PENNSYLVANICA POLLEN - UNII:2WZG2G15WX) FRAXINUS PENNSYLVANICA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-358-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-358-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-358-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-358-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    GUINEA PIG EPITHELIA 
    guinea pig epithelia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-012
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CAVIA PORCELLUS SKIN (UNII: GM3H4U6QS8) (CAVIA PORCELLUS SKIN - UNII:GM3H4U6QS8) CAVIA PORCELLUS SKIN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-012-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-012-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-012-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-012-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    HACKBERRY POLLEN 
    celtis occidentalis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-336
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CELTIS OCCIDENTALIS POLLEN (UNII: 68R9X9Y96X) (CELTIS OCCIDENTALIS POLLEN - UNII:68R9X9Y96X) CELTIS OCCIDENTALIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-336-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-336-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-336-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-336-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    HAMSTER EPITHELIA 
    hamster epithelia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-013
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MESOCRICETUS AURATUS SKIN (UNII: 3K873H631W) (MESOCRICETUS AURATUS SKIN - UNII:3K873H631W) MESOCRICETUS AURATUS SKIN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-013-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-013-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-013-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-013-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    HARD MAPLE POLLEN 
    acer saccharum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-452
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACER SACCHARUM POLLEN (UNII: V38QUQ7861) (ACER SACCHARUM POLLEN - UNII:V38QUQ7861) ACER SACCHARUM POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-452-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-452-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-452-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-452-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    HAZELNUT POLLEN 
    corylus americana injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-340
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CORYLUS AMERICANA POLLEN (UNII: ZGS382Y3AV) (CORYLUS AMERICANA POLLEN - UNII:ZGS382Y3AV) CORYLUS AMERICANA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-340-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-340-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-340-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-340-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    HELMINTHOSPORIUM SATIVUM 
    helminthosporium sativum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-112
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COCHLIOBOLUS SATIVUS (UNII: 3LN5B70U4W) (COCHLIOBOLUS SATIVUS - UNII:3LN5B70U4W) COCHLIOBOLUS SATIVUS 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-112-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-112-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-112-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-112-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    HOG EPITHELIA 
    hog epithelia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-014
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SUS SCROFA SKIN (UNII: 3EM4VW6TQN) (SUS SCROFA SKIN - UNII:3EM4VW6TQN) SUS SCROFA SKIN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-014-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-014-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-014-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-014-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    HORSE EPITHELIA 
    horse epithelia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-015
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EQUUS CABALLUS SKIN (UNII: 88VZV9HGT4) (EQUUS CABALLUS SKIN - UNII:88VZV9HGT4) EQUUS CABALLUS SKIN 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-015-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-015-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-015-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-015-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    HOUSE DUST 
    house dust injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-008
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HOUSE DUST (UNII: EYO007VX98) (HOUSE DUST - UNII:EYO007VX98) HOUSE DUST 0.02 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-008-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-008-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-008-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-008-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    IODINE BUSH POLLEN 
    allenrolfea occidentalis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-311
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALLENROLFEA OCCIDENTALIS POLLEN (UNII: 5W6JAI84OI) (ALLENROLFEA OCCIDENTALIS POLLEN - UNII:5W6JAI84OI) ALLENROLFEA OCCIDENTALIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-311-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-311-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-311-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-311-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    JOHNSON GRASS POLLEN 
    sorghum halepense injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-413
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SORGHUM HALEPENSE POLLEN (UNII: 577VA5B4HP) (SORGHUM HALEPENSE POLLEN - UNII:577VA5B4HP) SORGHUM HALEPENSE POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-413-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-413-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-413-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-413-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    JUTE 
    jute injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-016
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CORCORUS CAPSULARIS FIBER (UNII: TVA75O7S63) (CORCORUS CAPSULARIS FIBER - UNII:TVA75O7S63) CORCORUS CAPSULARIS FIBER 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-016-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-016-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-016-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-016-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    KAPOK 
    kapok injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-017
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CEIBA PENTANDRA FIBER (UNII: 758Z9H9WV9) (CEIBA PENTANDRA FIBER - UNII:758Z9H9WV9) CEIBA PENTANDRA FIBER 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-017-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-017-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-017-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-017-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    KARAYA GUM 
    karaya gum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-018
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KARAYA GUM (UNII: 73W9IQY50Q) (KARAYA GUM - UNII:73W9IQY50Q) KARAYA GUM 0.01 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-018-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-018-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-018-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-018-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    KOELERS GRASS POLLEN 
    koeleria cristata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-375
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KOELERIA MACRANTHA POLLEN (UNII: IIC6H3WF6J) (KOELERIA MACRANTHA POLLEN - UNII:IIC6H3WF6J) KOELERIA MACRANTHA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-375-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-375-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-375-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-375-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    LAMBS QUARTERS POLLEN 
    chenopodium album injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-339
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CHENOPODIUM ALBUM POLLEN (UNII: 098LKX5NCN) (CHENOPODIUM ALBUM POLLEN - UNII:098LKX5NCN) CHENOPODIUM ALBUM POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-339-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-339-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-339-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-339-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    LENS SCALE POLLEN 
    atriplex lentiformis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-440
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ATRIPLEX LENTIFORMIS POLLEN (UNII: 86LWA5503I) (ATRIPLEX LENTIFORMIS POLLEN - UNII:86LWA5503I) ATRIPLEX LENTIFORMIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-440-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-440-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-440-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-440-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    LINDEN POLLEN 
    tilia cordata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-460
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TILIA CORDATA POLLEN (UNII: OCO1LJR5YN) (TILIA CORDATA POLLEN - UNII:OCO1LJR5YN) TILIA CORDATA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-460-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-460-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-460-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-460-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    LOMBARD POPLAR POLLEN 
    populus nigra injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-397
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POPULUS NIGRA POLLEN (UNII: 0MGE63QPFJ) (POPULUS NIGRA POLLEN - UNII:0MGE63QPFJ) POPULUS NIGRA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-397-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-397-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-397-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-397-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    MELALEUCA POLLEN 
    melaleuca leucadendron injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-380
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MELALEUCA QUINQUENERVIA POLLEN (UNII: NX974IRT8E) (MELALEUCA QUINQUENERVIA POLLEN - UNII:NX974IRT8E) MELALEUCA QUINQUENERVIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-380-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-380-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-380-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-380-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    MESQUITE POLLEN 
    prosopis juliflora injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-400
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PROSOPIS JULIFLORA POLLEN (UNII: 6EIJ3D04MR) (PROSOPIS JULIFLORA POLLEN - UNII:6EIJ3D04MR) PROSOPIS JULIFLORA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-400-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-400-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-400-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-400-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    MONILIA 
    monilia sitophila injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-113
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CHRYSONILIA SITOPHILA (UNII: 296FK85FY6) (CHRYSONILIA SITOPHILA - UNII:296FK85FY6) CHRYSONILIA SITOPHILA 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-113-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-113-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-113-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-113-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    MOUNTAIN CEDAR POLLEN 
    juniperus sabinoides injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-371
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS ASHEI POLLEN (UNII: 544F8MEY0Y) (JUNIPERUS ASHEI POLLEN - UNII:544F8MEY0Y) JUNIPERUS ASHEI POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-371-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-371-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-371-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-371-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    MOUSE EPITHELIA 
    mouse epithelia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-019
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MUS MUSCULUS SKIN (UNII: 390AN9GB09) (MUS MUSCULUS SKIN - UNII:390AN9GB09) MUS MUSCULUS SKIN 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-019-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-019-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-019-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-019-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    MUCOR 
    mucor racemosus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-114
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MUCOR RACEMOSUS (UNII: 17RH99LQ7G) (MUCOR RACEMOSUS - UNII:17RH99LQ7G) MUCOR RACEMOSUS 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-114-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-114-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-114-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-114-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    MUGWORT SAGE POLLEN 
    artemisia vulgaris injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-321
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ARTEMISIA VULGARIS POLLEN (UNII: ANT994T71D) (ARTEMISIA VULGARIS POLLEN - UNII:ANT994T71D) ARTEMISIA VULGARIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-321-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-321-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-321-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-321-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    MUSTARD POLLEN 
    brassica campestris injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-327
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BRASSICA RAPA POLLEN (UNII: 85Z8OHV3K7) (BRASSICA RAPA POLLEN - UNII:85Z8OHV3K7) BRASSICA RAPA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-327-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-327-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-327-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-327-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    NETTLE POLLEN 
    urtica dioica injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-423
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    URTICA DIOICA POLLEN (UNII: DNB59M1NVU) (URTICA DIOICA POLLEN - UNII:DNB59M1NVU) URTICA DIOICA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-423-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-423-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-423-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-423-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ORRIS ROOT 
    orris root injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-020
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    IRIS GERMANICA VAR. FLORENTINA ROOT (UNII: M30XO5X4XD) (IRIS GERMANICA VAR. FLORENTINA ROOT - UNII:M30XO5X4XD) IRIS GERMANICA VAR. FLORENTINA ROOT 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-020-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-020-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-020-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-020-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    PALO VERDE POLLEN 
    cercidium torreyana injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-338
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PARKINSONIA FLORIDA POLLEN (UNII: 57586C96ZL) (PARKINSONIA FLORIDA POLLEN - UNII:57586C96ZL) PARKINSONIA FLORIDA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-338-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-338-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-338-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-338-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    PECAN POLLEN 
    carya illinoinensis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-444
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARYA ILLINOINENSIS POLLEN (UNII: PYO4JR720Y) (CARYA ILLINOINENSIS POLLEN - UNII:PYO4JR720Y) CARYA ILLINOINENSIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-444-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-444-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-444-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-444-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    PENICILLIUM 
    penicillium chrysogenum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-115
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM (UNII: 3Y1PE1GCIG) (PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM - UNII:3Y1PE1GCIG) PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-115-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-115-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-115-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-115-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    PEPPER TREE POLLEN 
    schinus molle injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-412
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SCHINUS MOLLE POLLEN (UNII: M0G28FH9K1) (SCHINUS MOLLE POLLEN - UNII:M0G28FH9K1) SCHINUS MOLLE POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-412-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-412-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-412-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-412-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    PHOMA 
    phoma betae injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-116
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PLEOSPORA BETAE (UNII: V58BK047ES) (PLEOSPORA BETAE - UNII:V58BK047ES) PLEOSPORA BETAE 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-116-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-116-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-116-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-116-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    POVERTY WEED POLLEN 
    iva axillaris injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-363
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    IVA AXILLARIS POLLEN (UNII: 13KFG30UBR) (IVA AXILLARIS POLLEN - UNII:13KFG30UBR) IVA AXILLARIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-363-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-363-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-363-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-363-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    PRIVET POLLEN 
    ligustrum vulgare injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-376
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LIGUSTRUM VULGARE POLLEN (UNII: Y3FRX92Z0E) (LIGUSTRUM VULGARE POLLEN - UNII:Y3FRX92Z0E) LIGUSTRUM VULGARE POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-376-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-376-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-376-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-376-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    PULLULARIA 
    pullularia pullulans injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-117
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AUREOBASIDIUM PULLULANS VAR. PULLUTANS (UNII: D1A2NG69CK) (AUREOBASIDIUM PULLULANS VAR. PULLUTANS - UNII:D1A2NG69CK) AUREOBASIDIUM PULLULANS VAR. PULLUTANS 0.01 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-117-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-117-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-117-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-117-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    PUSSY WILLOW POLLEN 
    salix discolor injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-407
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SALIX DISCOLOR POLLEN (UNII: ER172J09FM) (SALIX DISCOLOR POLLEN - UNII:ER172J09FM) SALIX DISCOLOR POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-407-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-407-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-407-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-407-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    QUACKGRASS POLLEN 
    agropyron repens injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-307
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ELYMUS REPENS POLLEN (UNII: ON2T85TA2O) (ELYMUS REPENS POLLEN - UNII:ON2T85TA2O) ELYMUS REPENS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-307-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-307-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-307-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-307-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RABBITBUSH POLLEN 
    ambrosia deltoides injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-354
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMBROSIA DELTOIDEA POLLEN (UNII: O4AB4546TP) (AMBROSIA DELTOIDEA POLLEN - UNII:O4AB4546TP) AMBROSIA DELTOIDEA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-354-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-354-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-354-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-354-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RED ALDER POLLEN 
    alnus rubra injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-435
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALNUS RUBRA POLLEN (UNII: Z0F2YK1B7H) (ALNUS RUBRA POLLEN - UNII:Z0F2YK1B7H) ALNUS RUBRA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    WATER (UNII: 059QF0KO0R)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-435-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-435-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-435-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-435-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RED CEDAR POLLEN 
    juniperus virginiana injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-373
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS VIRGINIANA POLLEN (UNII: PY0JA16R2G) (JUNIPERUS VIRGINIANA POLLEN - UNII:PY0JA16R2G) JUNIPERUS VIRGINIANA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-373-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-373-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-373-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-373-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RED MAPLE POLLEN 
    acer rubrum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-434
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACER RUBRUM POLLEN (UNII: 700NK45C76) (ACER RUBRUM POLLEN - UNII:700NK45C76) ACER RUBRUM POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-434-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-434-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-434-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-434-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RED MULBERRY POLLEN 
    morus rubra injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-447
    Route of Administration SUBCUTANEOUS, INTRADERMAL, CUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MORUS RUBRA POLLEN (UNII: 9LYI4RTZ52) (MORUS RUBRA POLLEN - UNII:9LYI4RTZ52) MORUS RUBRA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-447-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-447-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-447-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-447-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RED OAK POLLEN 
    quercus rubra injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-450
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    QUERCUS RUBRA POLLEN (UNII: SVW19ET93C) (QUERCUS RUBRA POLLEN - UNII:SVW19ET93C) QUERCUS RUBRA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-450-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-450-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-450-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-450-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    REDROOT PIGWEED POLLEN 
    amaranthus retroflexus injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-314
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMARANTHUS RETROFLEXUS POLLEN (UNII: 73B14PX5FW) (AMARANTHUS RETROFLEXUS POLLEN - UNII:73B14PX5FW) AMARANTHUS RETROFLEXUS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-314-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-314-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-314-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-314-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RHIZOPUS 
    rhizopus oryzae injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-118
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RHIZOPUS ARRHIZUS VAR. ARRHIZUS (UNII: 8476849N1Y) (RHIZOPUS ARRHIZUS VAR. ARRHIZUS - UNII:8476849N1Y) RHIZOPUS ARRHIZUS VAR. ARRHIZUS 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-118-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-118-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-118-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-118-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RIVER/RED BIRCH POLLEN 
    betula nigra injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-443
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETULA NIGRA POLLEN (UNII: 93963RFO1P) (BETULA NIGRA POLLEN - UNII:93963RFO1P) BETULA NIGRA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-443-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-443-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-443-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-443-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ROCKY MTN. JUNIPER POLLEN 
    juniperus scopulorum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-372
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS SCOPULORUM POLLEN (UNII: 0G82TT8ZFY) (JUNIPERUS SCOPULORUM POLLEN - UNII:0G82TT8ZFY) JUNIPERUS SCOPULORUM POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-372-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-372-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-372-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-372-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    ROUGH MARSHELDER POLLEN 
    iva ciliata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-364
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    IVA ANNUA POLLEN (UNII: Y2U5S5PF22) (IVA ANNUA POLLEN - UNII:Y2U5S5PF22) IVA ANNUA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-364-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-364-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-364-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-364-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RUSSIAN OLIVE POLLEN 
    elaeagnus angustifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-346
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ELAEAGNUS ANGUSTIFOLIA POLLEN (UNII: 68P4F4M6VD) (ELAEAGNUS ANGUSTIFOLIA POLLEN - UNII:68P4F4M6VD) ELAEAGNUS ANGUSTIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-346-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-346-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-346-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-346-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RUSSIAN THISTLE POLLEN 
    salsola kali injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-410
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SALSOLA KALI POLLEN (UNII: 2MH135KC6G) (SALSOLA KALI POLLEN - UNII:2MH135KC6G) SALSOLA KALI POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-410-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-410-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-410-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-410-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    RUST, WHEAT 
    puccinia striiformis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-120
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PUCCINIA STRIIFORMIS VAR. STRIIFORMIS (UNII: 9NLW29GJAX) (PUCCINIA STRIIFORMIS VAR. STRIIFORMIS - UNII:9NLW29GJAX) PUCCINIA STRIIFORMIS VAR. STRIIFORMIS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-120-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-120-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-120-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-120-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SALT CEDAR POLLEN 
    tamarix gallica injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-415
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TAMARIX GALLICA POLLEN (UNII: 43IR7KR479) (TAMARIX GALLICA POLLEN - UNII:43IR7KR479) TAMARIX GALLICA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-415-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-415-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-415-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-415-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SALT GRASS POLLEN 
    distichlis spicata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-345
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DISTICHLIS SPICATA POLLEN (UNII: GOA51670YV) (DISTICHLIS SPICATA POLLEN - UNII:GOA51670YV) DISTICHLIS SPICATA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-345-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-345-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-345-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-345-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SANDBUR RAGWEED POLLEN 
    ambrosia bipinnatifida injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-353
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMBROSIA CHAMISSONIS POLLEN (UNII: 2Z41EEQ491) (AMBROSIA CHAMISSONIS POLLEN - UNII:2Z41EEQ491) AMBROSIA CHAMISSONIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-353-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-353-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-353-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-353-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SHAD SCALE POLLEN 
    atriplex confertifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-439
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ATRIPLEX CONFERTIFOLIA POLLEN (UNII: GG8WX068MX) (ATRIPLEX CONFERTIFOLIA POLLEN - UNII:GG8WX068MX) ATRIPLEX CONFERTIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-439-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-439-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-439-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-439-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SHAGBARK HICKORY POLLEN 
    carya ovata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-332
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARYA OVATA POLLEN (UNII: 54UN9R2798) (CARYA OVATA POLLEN - UNII:54UN9R2798) CARYA OVATA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-332-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-332-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-332-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-332-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SHEEP SORREL POLLEN 
    rumex acetosella injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-405
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RUMEX ACETOSELLA POLLEN (UNII: N52MIQ81ZW) (RUMEX ACETOSELLA POLLEN - UNII:N52MIQ81ZW) RUMEX ACETOSELLA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-405-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-405-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-405-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-405-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SHORTLEAF PINE POLLEN 
    pinus echinata injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-448
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PINUS ECHINATA POLLEN (UNII: 96LRW14765) (PINUS ECHINATA POLLEN - UNII:96LRW14765) PINUS ECHINATA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-448-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-448-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-448-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-448-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SILVER MAPLE POLLEN 
    acer saccharinum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-304
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ACER SACCHARINUM POLLEN (UNII: 95447163DG) (ACER SACCHARINUM POLLEN - UNII:95447163DG) ACER SACCHARINUM POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-304-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-304-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-304-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-304-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SILVER RAGWEED POLLEN 
    dicoria canescens injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-344
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DICORIA CANESCENS POLLEN (UNII: E9H4GR1NMP) (DICORIA CANESCENS POLLEN - UNII:E9H4GR1NMP) DICORIA CANESCENS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-344-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-344-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-344-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-344-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SISAL 
    sisal injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-021
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AGAVE SISALANA FIBER (UNII: MRJ91HVV4H) (AGAVE SISALANA FIBER - UNII:MRJ91HVV4H) AGAVE SISALANA FIBER 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-021-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-021-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-021-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-021-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SLENDER RAGWEED POLLEN 
    ambrosia tenuifolia injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-356
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMBROSIA TENUIFOLIA POLLEN (UNII: 57W5SO585B) (AMBROSIA TENUIFOLIA POLLEN - UNII:57W5SO585B) AMBROSIA TENUIFOLIA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-356-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-356-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-356-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-356-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SMOOTH BROME POLLEN 
    bromus inermis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-328
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BROMUS INERMIS POLLEN (UNII: 766QT72BK6) (BROMUS INERMIS POLLEN - UNII:766QT72BK6) BROMUS INERMIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-328-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-328-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-328-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-328-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SMUT, CORN 
    ustilago maydis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-122
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    USTILAGO MAYDIS (UNII: 4K7Z7K7SWG) (USTILAGO MAYDIS - UNII:4K7Z7K7SWG) USTILAGO MAYDIS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-122-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-122-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-122-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-122-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SMUT, JOHNSON GRASS 
    sphacelotheca cruenta injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-123
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SPORISORIUM CRUENTUM (UNII: GQM6LVU5V8) (SPORISORIUM CRUENTUM - UNII:GQM6LVU5V8) SPORISORIUM CRUENTUM 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-123-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-123-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-123-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-123-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SMUT, WHEAT 
    tilletia caries (tritici) injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-124
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TILLETIA CARIES (UNII: C7000B9PQI) (TILLETIA CARIES - UNII:C7000B9PQI) TILLETIA CARIES 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-124-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-124-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-124-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-124-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SPRING BIRCH POLLEN 
    betula fontinalis injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-441
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETULA OCCIDENTALIS POLLEN (UNII: R889N2L976) (BETULA OCCIDENTALIS POLLEN - UNII:R889N2L976) BETULA OCCIDENTALIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-441-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-441-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-441-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-441-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    STEMPHYLIUM 
    stemphylium botryosum injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-126
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PLEOSPORA TARDA (UNII: TPL549N9R8) (PLEOSPORA TARDA - UNII:TPL549N9R8) PLEOSPORA TARDA 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-126-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-126-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-126-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-126-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SUGAR BEET POLLEN 
    beta vulgaris injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-324
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETA VULGARIS POLLEN (UNII: W7NU4B5CIY) (BETA VULGARIS POLLEN - UNII:W7NU4B5CIY) BETA VULGARIS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-324-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-324-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-324-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-324-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SUNFLOWER POLLEN 
    helianthus annua injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-360
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HELIANTHUS ANNUUS POLLEN (UNII: 28D6K7E9IP) (HELIANTHUS ANNUUS POLLEN - UNII:28D6K7E9IP) HELIANTHUS ANNUUS POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-360-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-360-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-360-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-360-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    SWEET GUM POLLEN 
    liquidamber styraciflua injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-377
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LIQUIDAMBAR STYRACIFLUA POLLEN (UNII: 5Q246DS5BS) (LIQUIDAMBAR STYRACIFLUA POLLEN - UNII:5Q246DS5BS) LIQUIDAMBAR STYRACIFLUA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-377-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-377-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-377-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-377-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    TAG ALDER POLLEN 
    alnus rugosa injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-436
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALNUS INCANA SUBSP. RUGOSA POLLEN (UNII: 605T96G8Y5) (ALNUS INCANA SUBSP. RUGOSA POLLEN - UNII:605T96G8Y5) ALNUS INCANA SUBSP. RUGOSA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-436-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-436-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-436-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-436-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    TOBACCO LEAF 
    tobacco leaf injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-022
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TOBACCO LEAF (UNII: 6YR2608RSU) (TOBACCO LEAF - UNII:6YR2608RSU) TOBACCO LEAF 0.1 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-022-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-022-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-022-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-022-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    TREE OF HEAVEN POLLEN 
    ailanthus altissima injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-310
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AILANTHUS ALTISSIMA POLLEN (UNII: 2A64U81OQ3) (AILANTHUS ALTISSIMA POLLEN - UNII:2A64U81OQ3) AILANTHUS ALTISSIMA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0025 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.00125 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.53 g  in 1 mL
    PHENOL (UNII: 339NCG44TV) 0.004 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49643-310-05 5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    2 NDC:49643-310-10 10 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    3 NDC:49643-310-30 30 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    4 NDC:49643-310-50 50 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102211 03/12/1974
    UTAH JUNIPER POLLEN 
    juniperus osteosperma injection
    Product Information
    Product Type NON-STANDARDIZED ALLERGENIC Item Code (Source) NDC:49643-370
    Route of Administration INTRADERMAL, CUTANEOUS, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    JUNIPERUS OSTEOSPERMA POLLEN (UNII: 15L060HV8H) (JUNIPERUS OSTEOSPERMA POLLEN - UNII:15L060HV8H) JUNIPERUS OSTEOSPERMA POLLEN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength